People's care Diagnostic

People's care Diagnostic People's Care Diagnostic is an emerging Diagnostic Service provider on the horizon with a promise to ensure Quality, Reliability

For Booking Call 8076446184
10/04/2021

For Booking Call 8076446184

08/04/2021

Covid RT PCR Test Available

To Get Discount
Call - 8076446184

09/09/2014
07/07/2014

People's Care Diagnostic is an emerging Diagnostic Service provider on the horizon with a promise to ensure Quality, Reliability

Prevention is Better than Cure
07/07/2014

Prevention is Better than Cure

21/05/2014

Blood Test for T-tau Shows Promise for Diagnosing, Managing Concussions

Researchers believe they have found a protein detectable in blood that could be used to help rapidly diagnose a concussion, leading to better management of those affected. While the biomarker, total tau or T-tau, needs to be evaluated in larger studies, it raises hope that health practitioners may in the future be able to use blood tests to manage head injuries and make return-to-play decisions for athletes following a concussion.

20/05/2014

FDA Advisory Committee Recommends an HPV Test as a Primary Screen for Cervical Cancer

An FDA advisory panel has voted unanimously to recommend to the FDA that a human papilloma virus (HPV) test be approved for marketing in the U.S. as a primary screening tool for cervical cancer. Currently, only the Pap smear is used for primary testing and HPV tests are recommended only in conjunction with or as a follow up to Pap smears. If approved by the FDA, the HPV test might become an initial screening option for women.

19/05/2014

Colon Cancer Rates Decline, Highlighting Role of Screening

Colon cancer rates have dropped by as much as 30% for adults aged 50 and older in the U.S., according to the latest statistics published by the American Cancer Society (ACS). The report is based on data from several national programs and registries. While more needs to be done to ensure widespread access to screening, the new data suggest that improved use of colonoscopy, in particular among people 50 to 75 years of age, has contributed to lowering colorectal cancer rates.

During the decade 2001-2010, overall incidence of new cases decreased by approximately 3% per year, with the largest drops among adults 65 and older. According to the ACS report, "the dramatic declines in colorectal cancer incidence over the past decade have been attributed to the widespread uptake of colonoscopy screening, which increased from 19% in 2000 to 55% in 2010 among adults aged 50 to 75 years." Colon cancer death rates decreased by a similar rate, about 3% per year, among both men and women during the same time period.

Colorectal cancer, commonly known as colon cancer, is the third most common cancer and the third leading cause of cancer death among men and women in the U.S., says the ACS. Based on the most recent analysis, over 70,000 men and 65,000 women will be diagnosed with colorectal cancer in 2014 and approximately 26,000 men and 24,000 women will die of the disease. While the exact cause is not known, risk appears to be associated with certain genetic, dietary, and lifestyle factors. It is both preventable and treatable if detected early, and studies have shown that regular screening could prevent one-third of colorectal cancer deaths in this country.

Current guidelines by several health organizations recommend universal screening of people at average risk beginning at age 50. For those with one or more risk factors for colon cancer, the recommendations are for earlier, more aggressive and more frequent screening.

Advice on the type of tests and frequency of screening vary somewhat, but most of these groups agree that colonoscopy and sigmoidoscopy are the preferred methods of screening. They can help prevent cancer by finding pre-cancerous polyps so they can be removed before they develop into cancer. Other methods only detect cancer after it has developed. [For more on screening recommendations, including risk factors and types of tests used, see Screening Tests For Adults 50 and Up: Colorectal cancer.]

18/05/2014

Stool DNA Test Gets Nod from FDA Advisory Committee

A new option for colon cancer screening may soon be available. An advisory committee voted unanimously to recommend to the FDA that a stool DNA test be approved for marketing. Unlike other options, such as colonoscopy, the stool test is non-invasive and the sample can be collected at home with no need for bowel preparation or medication. The FDA is expected to make its decision on whether to allow the test to be marketed in the next few months.

18/05/2014

Now pathology test'S budget is in your Pocket

Address

T-205 Gautampuri
New
110053

Telephone

8802307023

Website

Alerts

Be the first to know and let us send you an email when People's care Diagnostic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to People's care Diagnostic:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram